| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2001;103:710.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Departments of Cardiology (D.C., G.B, A.N.) and Pathology (C.B., L.R., G.T.), University of Padua Medical School, Padua, Italy.
Correspondence to Gaetano Thiene, MD, Istituto di Anatomia Patologica, Via A. Gabelli, 61 - 35121 Padova, Italy. E-mail cardpath{at}ux1.unipd.it
| Abstract |
|---|
|
|
|---|
Methods and
ResultsAmong a series of 273 young (
35
years) victims of cardiovascular sudden death who were prospectively
studied from 1979 to 1998 in the Veneto Region of Italy, 12-lead ECG
was available in 96 cases. Thirteen (14%; 12 males and 1 female aged
24±8 years) had right precordial ST-segment elevation, either isolated
(9 cases) or associated with right bundle branch block (4 cases). At
autopsy, all patients had ARVC (92%) except one, who had no evidence
of structural heart disease. Compared with the 19 young sudden death
victims with ARVC and no ST-segment abnormalities from the same series,
those with AVRC and right precordial ST-segment elevation included
fewer competitive athletes (17% versus 58%;
P=0.03), more often died
suddenly at rest or during sleep (83% versus 26%;
P=0.003), and showed serial ECG
changes over time (83% versus 0;
P=0.015), polymorphic
ventricular tachycardia (33% versus 0;
P=0.016), and predominant fatty
replacement of the right ventricular anterior wall (58% versus 21%;
P=0.05),
ConclusionsRight precordial ST-segment elevation was found in 14% of young sudden death victims with available ECG. It mostly reflected underlying ARVC with predominant right ventricular anterior wall involvement and characterized a subgroup of patients who share with Brugada patients the propensity to die from nonexercise-related cardiac arrest and to exhibit dynamic ECG changes and polymorphic ventricular tachycardia.
Key Words: arrhythmogenic right ventricular dysplasia fibrillation death, sudden
| Introduction |
|---|
|
|
|---|
The aim of the present study was to assess the prevalence of this ECG marker for sudden death in young people, to investigate the underlying substrates, and to define the clinical profile of the sudden death victims in a large consecutive series of young people who died suddenly in the Veneto Region of Italy from 1979 to 1998.
| Methods |
|---|
|
|
|---|
Morphological Protocol
Macroscopic examination included measurements of
heart weight, chamber size, and wall thickness and inspection of the
coronary arteries (patency, origin, and course) and valves. The
following ventricular regions were systematically examined: inflow
tract, outflow tract, apex, posterolateral and anterolaterals walls of
both ventricles, and the interventricular septum. Several coronary
arterial segments and full-thickness blocks of myocardium were removed
for histological examination from each ventricular region in a plan
parallel to the short and long axis of the ventricles. All sections (5
to 7 µm thick) were stained with hematoxylin and eosin, Weigert-van
Gieson, and trichrome Heidenhain (azan) techniques. The specialized
conduction system was studied by serial sections, as previously
reported.8
ARVC
ARVC was diagnosed in the presence of gross and/or
histological evidence of regional or diffuse fatty or fibrofatty
replacement of the myocardium of the RV free wall reaching the
endocardium (ie, transmural) in the absence of other known cardiac or
noncardiac causes of death.9
Pathological findings were classified according the following 2
morphological
patterns6 9 : the
"fatty" variant was characterized by fatty replacement of the
myocardium, with or without tiny interstitial fibrosis, predominantly
in the RV anterior wall from the apex to the outflow tract, and the
"fibrofatty" pattern was characterized by fatty tissue and
replacement-type fibrosis, with involvement of the RV posteroinferior
wall.
Mechanism of Sudden Death
Sudden death was considered cardiovascular in origin
when the primary cause leading to cardiac arrest was found in the heart
or great vessel or other noncardiac causes were excluded. In the
absence of mechanical causes of cardiac arrest, such as rupture of the
heart or aorta or pulmonary thromboembolism, the mechanism of
cardiovascular sudden death was presumed to be
arrhythmic.
ECG Analysis
For the purposes of the present study, the analysis
of 12-lead ECG focused on heart rate; duration of PR and QT intervals;
duration, axis, and morphology of the QRS complex; epsilon waves;
degree and pattern of ST-segment displacement; T-wave configuration;
and ventricular arrhythmias. Duration of both QRS complex and QT
interval was measured in lead II. A normal QT interval was defined as a
rate-corrected (QTc by Bazzetts formula) interval
440
ms.7 Serial analysis of ECG
changes over time was performed in sudden death victims with
2
available ECG tracings.
Right precordial ST-segment elevation was defined as a
ST-segment that originated from a late R wave and was displaced upward
0.1 mV from the isoelectric line in leads V1 to V2/V3. T-wave
configuration was classified according to the direction of the
deflection as positive, negative, or biphasic. The diagnosis of RBBB
and left axis deviation was made according to the criteria of the World
Health Organization/International Society of Cardiology Task
Force.10
Clinicopathological Correlations
Patients with the ECG pattern of right precordial
ST-segment elevation, with or without RBBB aberrancy, in the absence of
coronary artery disease were selected for clinicopathological
correlation and compared with the group of ARVC patients without right
precordial ST-segment elevation from the same series, with respect to a
series of clinical and morphological variables.
Statistical Analysis
Continuous variables were expressed as mean±SD.
Fishers exact test was used to assess the significance of differences
between subgroups. A 2-tailed
P<0.05 was considered
statistically significant.
| Results |
|---|
|
|
|---|
|
Clinico-ECG Characteristics of Victims With
Right Precordial ST-Segment Elevation
Thirteen of the 96 patients with available ECGs (14%),
12 males and 1 female aged 10 to 35 years (mean, 24±8 years), had
nonischemic ECG changes that manifested as ST-segment elevation in
leads V1 to V2/V3. All patients had sinus rhythm with a rate-corrected
QT interval within normal limits; 2 patients had first-degree
atrioventricular (AV) block. A true RBBB was documented in 4 patients
(33%), and it was associated with left axis deviation in 2
(Figure 1A
); the other 9 patients had a RBBB-like pattern
that was limited to the right precordial leads and was associated with
a high takeoff ST-segment elevation
(Figure 2A
). The mean QRS duration was 95±8 ms in patients
with isolated ST-segment elevation and 115±8 ms in those with
associated RBBB.
|
|
Sudden death was unrelated to physical exercise in all but 2 victims (who were competitive athletes), and it occurred at rest in 9 patients or during sleep in 2. Five patients had a familial history of premature sudden death. Twelve-lead ECG was obtained after episodes of syncope (5 patients) or aborted sudden death (1 patient); in 5 of these patients, ventricular fibrillation (1 case) and nonsustained polymorphic ventricular tachycardia, which occurred at rest with a mean cycle length of 238±14 ms (4 cases), were documented at the time of aborted sudden death or by Holter monitoring after syncopal episodes, respectively. Seven sudden death victims were previously asymptomatic and the ECG was recorded during routine or screening cardiovascular evaluation. No patients were taking antiarrhythmic drugs when the ECG was recorded.
Dynamic changes over time of ST-segment elevation, up to
nearly complete ECG normalization, were observed in 5 of the 6 patients
in whom
2 recordings were available
(Figures 1B
and 2B
); these changes were recorded at similar
heart rates, and no rate-dependent changes were observed. Ventricular
arrhythmias with a left bundle branch block pattern had been documented on basal ECG, Holter monitoring, or
exercise testing in 7 cases, and they consisted of isolated premature
ventricular contractions (3 patients) and episodes of nonsustained (2
patients) or sustained (2 patients) ventricular tachycardia, all of
which occurred at rest with a mean cycle length of 327±4 ms. Among 5
patients (all symptomatic) who underwent angiography and/or
echocardiography, RV abnormalities were detected in
3.
Pathological Findings in Victims With Right
Precordial ST-Segment Elevation
Post-mortem investigation showed an organic heart
disease in all but 1 subject, who had a morphologically normal heart.
The structural changes in the remaining hearts were consistent with
ARVC. The heart weight ranged from 310 to 580 g (mean, 390±15 g).
Mild to moderate RV dilatation was seen in 7 of 12 hearts. Ventricular
bulgings were identified in 7 hearts at
1 of the following RV
locations: outflow tract (7 cases), posteroinferior wall (beneath the
posterior leaflet of the tricuspid valve; 3 cases), and apex (3 cases).
Nine bulgings had a translucent wall. Seven heart specimens showed a
fatty morphological pattern characterized by myocardial replacement
predominantly located in the RV anterior wall, and 5 had a fibrofatty
variant with involvement of the posteroinferior wall. In all cases,
histological examination showed a full-thickness involvement of the RV
free wall
(Figures 1C
and 2C
). The replacement of the myocardium was
predominantly located in the subepicardial and midmural layers, where
islands of residual myocardium appeared interspersed with fatty or
fibrofatty tissue; the subendocardium and the trabeculae showed a
greater amount of surviving myocardium with degenerative changes of
myocytes and increased interstitial or replacement-type fibrosis
(Figures 1C
, 1D
, and 2C
). The left ventricular myocardium was
substantially spared and only exhibited occasional focal spots of fatty
and/or fibrous tissue, mostly in the subepicardial layer, in 5 cases.
Multifocal inflammatory infiltrates consisting of interstitial
collections of lymphocytes and/or macrophages associated with myocyte
necrosis were seen in 8 hearts.
At the histological examination of the conduction system,
the sinus node and sinus node approaches were normal except in 2 cases
with mild fibrosis. The AV node and atrionodal approaches were normal.
In 3 of 4 cases with ECG evidence of true RBBB, there was moderate to
severe fibrosis of the branching bundle and proximal right bundle
branch
(Figures 1E
and 1F
), which appeared interrupted in one. In
this latter case, there was a slight fibrous atrophy of the proximal
tract of the left bundle branch.
Comparison Between ARVC Victims With and
Without ST-Segment Elevation
Among 36 young patients who died suddenly from ARVC
(see
Table 1
), 12-lead ECG was available in 31 (86%). Twelve
patients had right precordial ST-segment elevation (see above); in the
other 19, the ECG either showed inverted T waves from V1 to V2/V3
without ST-segment elevation (n=15) or was normal (n=4).
Tables 2
and 3
show the correlation between ARVC victims
with and without ST-segment elevation in right precordial leads with
respect to a series of clinical, morphological, and ECG findings. ECG
were examined serially in 6 patients with ST-segment elevation and in 5
patients without ST-segment elevation who had a mean of 5±2 and 6.0±2
ECG recordings, respectively. The time interval over which the serial
ECGs were examined was 23±17 and 25±15 months, respectively. The ARVC
victims with right precordial ST-segment elevation included fewer
competitive athletes (17% versus 58%;
P=0.03), more often experienced
sudden death unrelated to physical exercise (83% versus 26%;
P=0.003), showed dynamic
changes in right precordial ventricular repolarization (83% versus 0;
P=0.015) and polymorphic
ventricular tachycardia (33% versus 0;
P=0.016), and had a fatty
morphological pattern with prevalent myocardial replacement of RV
anterior wall (58% versus 21%;
P=0.05) compared with the
remaining ARVC victims with available ECGs that did not show ST-segment
changes.
|
|
| Discussion |
|---|
|
|
|---|
ECG Abnormalities
Most of the patients with the syndrome of RBBB and
right precordial ST-segment elevation described in the literature were
of South Asian origin.5 The
present study provides a prevalence of 14% of the pattern of RBBB
and/or right precordial ST-segment among the ECG recordings obtained
from a homogeneous series of young sudden death victims from the Veneto
Region of Italy, suggesting that this ECG abnormality is not rare in
Western countries and should be considered a worldwide marker of
arrhythmic sudden death.
A widened S-wave in left lateral leads, which is typical for RBBB,10 was observed in only 4 of the patients with right precordial ST-segment elevation (28%). This indicates that although the QRS complex/ST segment morphology in V1 to V2/V3 mimics RBBB, this pattern is limited to right precordial leads reflecting either a localized RV parietal (rather than a septal) block3 or a J-point elevation associated with a high takeoff ST segment elevation.11 Serial changes of the ST-segment elevation over time, up to transient normalization of the tracing, were noted in >80% of cases. Therefore, the previous concept that dynamic ECG changes are the proof against an underlying structural substrate12 13 14 is not in keeping with the present findings showing that ECG variations over time occur even in patients with organic heart disease, namely ARVC proven at autopsy. The variability of the autonomic nervous system activity modulating a conduction defect or a repolarization abnormality in the setting of a structural RV myocardial disease is the most likely explanation for these transient ECG changes.14 Of note, dynamic changes of repolarization were never observed in ARVC patients without ST-segment elevation. Although statistically significant, this difference may have been overestimated because of the small number of both patients with serial ECG and ECG serially examined in each patient from both subgroups.
Peters et al15 recently reported that right precordial ST-segment elevation was not a risk factor for sudden death in patients with ARVC. However, in contrast to the present study, their analysis did not focus on high takeoff ST-segment elevation and included any nonspecific upward displacement of the ST-segment accompanying right precordial T-wave inversion.
Pathological Substrates
Morphological studies in sudden death victims with the
ECG pattern of RBBB and right precordial ST-segment elevation are rare
and limited to case
reports.1 3 16 17
However, when available, autopsy findings consistently show fibrofatty
replacement of RV myocardium, frequently associated with a conduction
system
pathology.1 3 17
We previously studied 16 members of an affected family and demonstrated
that structural abnormalities of both the RV myocardium and the
specialized conduction system may present clinically as RBBB, right
precordial ST-segment elevation, and sudden
death.3 The present study
extended our earlier observations and showed that a structural heart
disease, namely ARVC, was the most prevalent substrate underlying the
above ECG abnormalities in a homogeneous series of young sudden death
victims. A functional electrical disease (like Brugada syndrome) could
have accounted for ECG abnormalities and arrhythmic cardiac arrest in
the only heart that did not exhibit any structural abnormality. These
findings may be reasonably explained by the accurate morphological
protocol for investigation of the RV in the present study.
In patients with transient right precordial ST-segment elevation and vagal-induced ventricular fibrillation, Kansamuki et al2 used body-surface mapping to demonstrate conduction abnormalities that were predominantly localized between the anterior RV wall and the outflow tract; they advanced the hypothesis that this clinical condition may reflect an early subclinical stage of ARVC characterized by a segmental lesion. The pathological findings in our sudden death victims with right precordial ST-segment were all consistent with a widespread form of ARVC that did not differ, in terms of cardiomegaly and extent of myocardial atrophy with fibrofatty replacement, from that without ST-segment abnormalities. However, ARVC patients with right precordial ST segment elevation did tend to have a fatty morphological pattern, characterized by myocardial replacement predominantly located in the RV anterior wall. This pathological finding may account for the clinical, ECG, and pathophysiological differences among the 2 patient subgroups.
Kirschner et al18 performed autopsy studies in South Asian victims of sudden unexplained death syndrome in 1986 when the morphological features of ARVC were still incompletely known and found structural changes in the specialized conduction system in 14 of the 18 hearts. In the present study, the histological examination of the conduction system showed the involvement of the branching bundle and proximal right bundle branch, ranging from mild fibrous atrophy to interruption, in 3 of 4 patients with the ECG pattern of true RBBB. These findings confirm that a structural His-Purkinje system disease may underlie the electrophysiological finding of prolonged HV interval in a subset of patients with the RBBB and right precordial ST-segment.1 3
Mechanisms of ST-Segment Elevation and
Ventricular Arrhythmias
The ventricular arrhythmogenicity of ARVC is
traditionally explained by the existence of islands of surviving
myocardium surrounded by fibrofatty tissue, which acts as a substrate
for an inhomogeneous intraventricular conduction predisposing to
re-entrant ventricular
arrhythmias.19 These
depolarization abnormalities are mediated by a sympathetic mechanism
that distinctively predispose to sudden death during enhanced
adrenergic drive, such as that during physical
activity.6 7 19
Instead, in the majority of patients with Brugada and related
syndromes, the malignant ventricular arrhythmias occur at rest and, in
many cases, at
night2 4 5 13 20 ;
a sudden rise of vagal activity reportedly occurs just before
ventricular fibrillation
episodes.4 The results of the
present study suggest that increased vagal activity and/or withdrawal
of sympathetic activity may even play a significant arrhythmogenic role
in the subset of ARVC patients with right precordial ST segment
elevation who show a propensity to die suddenly at rest or during
sleep. Like patients with Brugada syndrome, the presumed arrhythmogenic
mechanisms in this group of patients is a vagal-induced ventricular
fibrillation originating in the setting of a dispersion of RV
repolarization.
Studies by Antzelevitch and others11 21 22 provided experimental evidence that a heterogeneous distribution of action potential duration across the RV wall may be the basis for both a right precordial ST segment elevation and rapid ventricular arrhythmias (polymorphic ventricular tachycardia or ventricular fibrillation), which may be precipitated by enhanced parasympathetic activity. A series of pathological conditions or pharmacological interventions, such as sodium channel blockade, may result in the loss of the action potential dome in the epicardium (but not in the endocardium) and provoke a transmural current flow from epicardium to endocardium, which accounts for ST-segment elevation. Moreover, propagation of the action potential dome from sites at which it is maintained to sites at which it is abolished may result in local reexcitation (phase 2 reentry), and this may induce very rapid ventricular arrhythmias in the form of polymorphic ventricular tachycardia or ventricular fibrillation. Litovsky and Antzelevitch23 demonstrated that acetylcholine facilitates the loss of the action potential dome and accentuates both ST-segment elevation and dishomogeneity of ventricular repolarization by suppressing the calcium current and/or augmenting the potassium current.
In Brugada syndrome, a genetically induced sodium channel dysfunction resulting in reduced current density is the most likely mechanism of the loss of the epicardial action potential dome with transmural dispersion of repolarization, which in turn may predispose to the development of ventricular fibrillation.24 In the present study, the ARVC lesions predominantly involved the epicardial and midmural layers and created a transmural gradient of myocyte degeneration and death in the setting of fibrofatty replacement. This pathological substrate potentially accounted for a "structural" epicardial-endocardial heterogeneity of repolarization in the RV wall predisposing to phase 2 reentry. Accordingly, experimental damage of canine ventricular epicardium secondary to metabolic inhibition and simulated ischemia provoked electrical inhomogeneity and local reexcitation.11 25 In addition, Krishan and Antzelevitch26 showed a synergism between heterogeneous repolarization and delayed conduction in giving rise to arrhythmic activity in canine ventricular epicardium. In our sudden death victims, therefore, a delayed intraventricular conduction caused by the disarrangement of surviving myocardium in islands interspersed with fibrofatty tissue may have contributed to the induction and maintenance of reentrant activity, in association with the dispersion of repolarization.
Study Limitations
No patients in this study underwent pharmacological
testing with sodium-channel blockers designed to induce or enhance
ST-segment elevation in right precordial leads, which is a typical
finding in Brugada syndrome, because they were generally asymptomatic
before death.
ECG monitoring of ST-segment elevation to predict a higher risk of sudden death or to identify a group with a different genetic background cannot be inferred from this retrospective analysis of sudden death victims and should be tested in prospective studies in living ARVC patients.
| Acknowledgments |
|---|
Received July 31, 2000; revision received September 20, 2000; accepted September 20, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Peters Arrhythmogenic right ventricular dysplasia-cardiomyopathy and provocable coved-type ST-segment elevation in right precordial leads: clues from long-term follow-up Europace, July 1, 2008; 10(7): 816 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Furushima, M. Chinushi, K. Okamura, K. Iijima, S. Komura, Y. Tanabe, S. Okada, D. Izumi, and Y. Aizawa Comparison of conduction delay in the right ventricular outflow tract between Brugada syndrome and right ventricular cardiomyopathy: investigation of signal average ECG in the precordial leads Europace, October 1, 2007; 9(10): 951 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Stephenson and C. I. Berul Electrophysiological Interventions for Inherited Arrhythmia Syndromes Circulation, August 28, 2007; 116(9): 1062 - 1080. [Full Text] [PDF] |
||||
![]() |
R. Coronel, G. Berecki, and T. Opthof Why the Brugada syndrome is not yet a disease: Syndromes, diseases, and genetic causality Cardiovasc Res, December 1, 2006; 72(3): 361 - 363. [Full Text] [PDF] |
||||
![]() |
D. Corrado, C. Basso, A. Pavei, P. Michieli, M. Schiavon, and G. Thiene Trends in Sudden Cardiovascular Death in Young Competitive Athletes After Implementation of a Preparticipation Screening Program JAMA, October 4, 2006; 296(13): 1593 - 1601. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Saffitz Structural Heart Disease, SCN5A Gene Mutations, and Brugada Syndrome: A Complex Menage a Trois Circulation, December 13, 2005; 112(24): 3672 - 3674. [Full Text] [PDF] |
||||
![]() |
A. Frustaci, S. G. Priori, M. Pieroni, C. Chimenti, C. Napolitano, I. Rivolta, T. Sanna, F. Bellocci, and M. A. Russo Cardiac Histological Substrate in Patients With Clinical Phenotype of Brugada Syndrome Circulation, December 13, 2005; 112(24): 3680 - 3687. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Coronel, S. Casini, T. T. Koopmann, F. J.G. Wilms-Schopman, A. O. Verkerk, J. R. de Groot, Z. Bhuiyan, C. R. Bezzina, M. W. Veldkamp, A. C. Linnenbank, et al. Right Ventricular Fibrosis and Conduction Delay in a Patient With Clinical Signs of Brugada Syndrome: A Combined Electrophysiological, Genetic, Histopathologic, and Computational Study Circulation, November 1, 2005; 112(18): 2769 - 2777. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Meregalli, A. A.M. Wilde, and H. L. Tan Pathophysiological mechanisms of Brugada syndrome: Depolarization disorder, repolarization disorder, or more? Cardiovasc Res, August 15, 2005; 67(3): 367 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch, P. Brugada, M. Borggrefe, J. Brugada, R. Brugada, D. Corrado, I. Gussak, H. LeMarec, K. Nademanee, A. R. Perez Riera, et al. Brugada Syndrome: Report of the Second Consensus Conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association Circulation, February 8, 2005; 111(5): 659 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron, B. R. Chaitman, M. J. Ackerman, A. Bayes de Luna, D. Corrado, J. E. Crosson, B. J. Deal, D. J. Driscoll, N.A. M. Estes III, C. G. S. Araujo, et al. Recommendations for Physical Activity and Recreational Sports Participation for Young Patients With Genetic Cardiovascular Diseases Circulation, June 8, 2004; 109(22): 2807 - 2816. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ahn and J. W. Hurst Worrisome Thoughts About the Diagnosis and Treatment of Patients With Brugada Waves and the Brugada Syndrome Circulation, March 30, 2004; 109(12): 1463 - 1467. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wang, R. W. Asinger, and H. J.L. Marriott ST-Segment Elevation in Conditions Other Than Acute Myocardial Infarction N. Engl. J. Med., November 27, 2003; 349(22): 2128 - 2135. [Full Text] [PDF] |
||||
![]() |
B Martini More evidence-based data are required for a consensus on the aetiology of the so-called Brugada Syndrome Eur. Heart J., November 2, 2003; 24(22): 2072 - 2072. [Full Text] [PDF] |
||||
![]() |
A.A.M Wilde and C Antzelevitch The continuing story: The aetiology of Brugada syndrome: functional or structural basis? Eur. Heart J., November 2, 2003; 24(22): 2073 - 2073. [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch, P. Brugada, J. Brugada, R. Brugada, J. A. Towbin, and K. Nademanee Brugada syndrome: 1992-2002: A historical perspective J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1665 - 1671. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch, P. Brugada, J. Brugada, R. Brugada, W. Shimizu, I. Gussak, and A.R. Perez Riera Brugada Syndrome: A Decade of Progress Circ. Res., December 13, 2002; 91(12): 1114 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A.M. Wilde, C. Antzelevitch, M. Borggrefe, J. Brugada, R. Brugada, P. Brugada, D. Corrado, R. N.W. Hauer, R. S. Kass, K. Nademanee, et al. Proposed Diagnostic Criteria for the Brugada Syndrome: Consensus Report Circulation, November 5, 2002; 106(19): 2514 - 2519. [Full Text] [PDF] |
||||
![]() |
A.A.M. Wilde, C. Antzelevitch, M. Borggrefe, J. Brugada, R. Brugada, P. Brugada, D. Corrado, R.N.W. Hauer, R.S. Kass, K. Nademanee, et al. Proposed Diagnostic Criteria for the Brugada Syndrome Eur. Heart J., November 1, 2002; 23(21): 1648 - 1654. [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch Brugada syndrome: historical perspectives and observations Eur. Heart J., April 2, 2002; 23(8): 676 - 678. [Full Text] [PDF] |
||||
![]() |
B. Surawicz Brugada syndrome: manifest, concealed, "asymptomatic," suspected and simulated J. Am. Coll. Cardiol., September 1, 2001; 38(3): 775 - 777. [Full Text] [PDF] |
||||